Representative publications in reverse:
- Yulin Wu, Juan Zhang, Hongxi Xu, Yuanyang Tian, William Chi Shing Cho, Zhi-Xiu Lin, Yan-Fang Xian*. 20(S)-Ginsenoside Rh2 Overcomes Gemcitabine Resistance in Pancreatic Cancer by Inhibiting LAMC2 Expression. Journal of Advanced Research, 2024 Sep 11:S2090-1232(24)00390-4. (IF:11.4)
- Yulin Wu, Yan-Fang Xian, Juan Zhang, Jun Guo, Zhi-Xiu Lin; Can Prostate Cancer Patients be Prescribed Chinese Herbal Medicine? A Review of its Potential Modulatory Effects on the Androgen Receptor, Integrative Medicine in Nephrology and Andrology, 2024; 11:e23-00027.
- Juan Zhang, Yulin Wu*, Yuanyang Tian, Hongxi Xu, Zhi-Xiu Lin and Yan-Fang Xian. Chinese herbal medicine for the treatment of intestinal cancer: preclinical studies and potential clinical applications, Molecular Cancer, (2024) 23:217. (IF:27.5)
|